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ABSTRACT 
Itraconazole and fluconazole are oral antifungal drugs, which have a wide spectrum 
antifungal activity and better efficacy than the older drugs. However, both drugs have been 
associated with hepatotoxicity in susceptible patients. The mechanism of antifungal drug-
induced hepatotoxicity is largely unknown. Therefore, the aim of this present study was to 
investigate and compare the hepatotoxicity induced by these drugs in vivo. Rats were treated 
intraperitoneally with itraconazole or fluconazole either single (0, 10, 100 and 200 mg/kg) or 
subchronic (0, 10, 50 and 100 mg/kg per day for 14 days) doses. Plasma and liver samples 
were taken at the end of the study. A statistically significant and dose dependent increase of 
plasma alanine aminotransferase (ALT) and alkaline phosphatase [ALP) activities were 
detected in the subchronic itraconazole-treated group. In addition, dose-dependent 
hepatocellular necrosis, degeneration of periacinar and mizonal hepatocytes, bile duct 
hyperplasia and biliary cirrhosis and giant cell granulome were observed histologically in the 
same group. Interestingly, fluconazole treated rats had no significant increase in 
transaminases for both single and subchronic groups. In the subchronic fluconazole treated 
rats, only mild degenerative changes of centrilobular hepatocytes were observed. These 
results demonstrated that itraconazole was a more potent hepatotoxicant than fluconazole in 
vivo in rats. 
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